A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication

被引:68
作者
Kussick, SJ
Stirewalt, DL
Yi, HS
Sheets, KM
Pogosova-Agadjanyan, E
Braswell, S
Norwood, TH
Radich, JP
Wood, BL
机构
[1] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
acute myeloid leukemia; Flt3; CD123; CD133; HLA-DR; nuclear invagination;
D O I
10.1038/sj.leu.2403458
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a 5-year survey of nonpromyelocytic/nonmonocytic acute myeloid leukemias (AMLs) diagnosed in the University of Washington Hematopathology Laboratory, we identified 19 cases containing distinctive, cup-like nuclear indentation in 10% or more of the blasts ('AML-cuplike'). Fourteen of these cases (74%) demonstrated near-complete loss of HLA-DR expression, while the other five cases showed partial loss of HLA-DR. A total of 16 of the cases (84%) demonstrated internal tandem duplication (ITD) of the Flt3 gene. When compared to a selected set of AMLs lacking this nuclear morphology, AML-cuplike was significantly more likely to lack HLA-DR and CD34 expression, to express CD123 without CD133, to have a normal karyotype, and to harbor the Flt3 ITD. To characterize AML-cuplike in an unselected series of AMLs, we analyzed 42 consecutive nonpromyelocytic/nonmonocytic AMLs diagnosed in our laboratory during a 6-month period in 2002. Strikingly, in this unselected series, there was a statistically significant coincidence of invaginated nuclear morphology, loss of HLA-DR, and presence of the Flt3 ITD beyond that expected if these three features were unrelated, suggesting that AMLs with these three features may represent a distinct AML subset.
引用
收藏
页码:1591 / 1598
页数:8
相关论文
共 26 条
[1]   FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia [J].
Arrigoni, P ;
Beretta, C ;
Silvestri, D ;
Rossi, V ;
Rizzari, C ;
Valsecchi, MG ;
Cazzaniga, G ;
Biondi, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :89-92
[2]   DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA BY RT-PCR - DETECTION OF PML-RARA AND RARA-PML FUSION TRANSCRIPTS [J].
BORROW, J ;
GODDARD, AD ;
GIBBONS, B ;
KATZ, F ;
SWIRSKY, D ;
FIORETOS, T ;
DUBE, I ;
WINFIELD, DA ;
KINGSTON, J ;
HAGEMEIJER, A ;
REES, JKH ;
LISTER, TA ;
SOLOMON, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (03) :529-540
[3]   The roles of FLT3 in hematopoiesis and leukemia [J].
Gilliland, DG ;
Griffin, JD .
BLOOD, 2002, 100 (05) :1532-1542
[4]   Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines [J].
Hayakawa, F ;
Towatari, M ;
Kiyoi, H ;
Tanimoto, M ;
Kitamura, T ;
Saito, H ;
Naoe, T .
ONCOGENE, 2000, 19 (05) :624-631
[5]   Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia [J].
Iwai, T ;
Yokota, S ;
Nakao, M ;
Okamoto, T ;
Taniwaki, M ;
Onodera, N ;
Watanabe, A ;
Kikuta, A ;
Tanaka, A ;
Asami, K ;
Sekine, I ;
Mugishima, H ;
Nishimura, Y ;
Koizumi, S ;
Horikoshi, Y ;
Mimaya, J ;
Ohta, S ;
Nishikawa, K ;
Iwai, A ;
Shimokawa, T ;
Nakayama, M ;
Kawakami, K ;
Gushiken, T ;
Hyakuna, N ;
Katano, N ;
Tsurusawa, M ;
Fujimoto, T .
LEUKEMIA, 1999, 13 (01) :38-43
[6]  
Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3
[7]  
Kiyoi H, 1999, BLOOD, V93, P3074
[8]   Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product [J].
Kiyoi, H ;
Towatari, M ;
Yokota, S ;
Hamaguchi, M ;
Ohno, R ;
Saito, H ;
Naoe, T .
LEUKEMIA, 1998, 12 (09) :1333-1337
[9]   The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials [J].
Kottaridis, PD ;
Gale, RE ;
Frew, ME ;
Harrison, G ;
Langabeer, SE ;
Belton, AA ;
Walker, H ;
Wheatley, K ;
Bowen, DT ;
Burnett, AK ;
Goldstone, AH ;
Linch, DC .
BLOOD, 2001, 98 (06) :1752-1759
[10]  
Kussick SJ, 2003, ARCH PATHOL LAB MED, V127, P1140